Arbutus Biopharma Corp
SWB:I9DN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arbutus Biopharma Corp
SWB:I9DN
|
CA |
|
Aecon Group Inc
TSX:ARE
|
CA |
|
Agricultural Bank of China Ltd
F:EK7
|
CN |
|
EVIO Inc
OTC:EVIO
|
US |
|
K
|
Kerry Properties Ltd
F:KR3
|
HK |
|
M
|
Mr Blue Corp
KOSDAQ:207760
|
KR |
|
Thesis Gold Inc
XTSX:TAU
|
CA |
|
Hi Steel Co Ltd
KRX:071090
|
KR |
|
Metall Zug AG
LSE:0QLX
|
CH |
|
H
|
Hoshizaki Corp
SWB:HS0
|
JP |
|
C
|
Corbion NV
F:CSU
|
NL |
|
Rackspace Technology Inc
NASDAQ:RXT
|
US |
|
Buxton Resources Ltd
ASX:BUX
|
AU |
|
H
|
Hankuk Steel Wire Co Ltd
KOSDAQ:025550
|
KR |
Shareholder Yield
Current shareholder yield for 
I9DN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
I9DN Price
Arbutus Biopharma Corp
| Average Annual Return | 6.77% |
| Standard Deviation of Annual Returns | 29.59% |
| Max Drawdown | -64% |
| Market Capitalization | 832m EUR |
| Shares Outstanding | 180 192 227 |
| Percentage of Shares Shorted |
N/A
|
